As I mentioned earlier, we were interested in getting our compounds screened by the Developmental Therapeutics Program (DTP) at the National Cancer Institute. The first entry is now done and from what I understand it will be 8-10 business days before we get a request for the compound after they check for uniqueness.
This is good timing because it really is time to gather up all of the isolated and characterized compounds in UsefulChem on one page, which is now linked on the left navigation bar on the wiki. This page should also be used by other people interested in screening who want to quickly see what we have on hand. Right now we have a few boc protected and deprotected Ugi products, and these will be added to the page shortly.
Dan has also joined the wiki and created a page to detail the DTP-NCI process. He is inviting us to comment on the process there to understand and improve it.
Jean-Claude Bradley
Jean-Claude Bradley is an Associate Professor of Chemistry and the E-Learning Coordinator for the College of Arts and Sciences at Drexel University in Philadelphia, PA.
He teaches organic chemistry and runs UsefulChem, an open source science project dealing with the synthesis of anti-malarial compounds.
Chemistry Wide Open
